Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
17.66
+0.38 (2.20%)
Aug 21, 2026, 12:58 PM EDT - Market open
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $1.08 billion as of August 21, 2026. Its market cap has decreased by -27.76% in one year.
Market Cap
1.08B
Enterprise Value
129.75M
1-Year Change
-27.76%
Ranking
Category
Stock Price
$17.66
ChartMarket Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $1.08B, an increase of 75.92%. That is a compound annual growth rate of 11.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 1.08B | 30.08% |
| Dec 31, 2025 | 830.04M | -73.11% |
| Dec 31, 2024 | 3.09B | 523.34% |
| Dec 29, 2023 | 495.20M | -9.51% |
| Dec 30, 2022 | 547.22M | -33.35% |
| Dec 31, 2021 | 821.00M | 33.77% |
| Jun 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Apnimed | 1.14B |
| Sana Biotechnology | 1.12B |
| Inventiva | 1.09B |
| Avalo Therapeutics | 1.06B |
| Kura Oncology | 1.04B |
| Wave Life Sciences | 1.03B |
| Geron | 995.83M |
| Annexon | 982.02M |